US Patent 7538140 Ester compound and medicinal use thereof
Patent 7538140 was granted and assigned to Japan Tobacco on May, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Atsushi Hagiwara0
Kenya Madono0
Naoya Odani0
Shizue Watanabe0
Takashi Kawai0
Taku Ikenogami0
Toshio Taniguchi0
Yasuhiro Ohe0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+119 characters)
Article
Patent abstract
A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1″)
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07538140 Ester compound and medicinal use thereof US Patent 7538140 Ester compound and medicinal use thereof
Infobox
Patent Number
075381400
Patent Number
75381400
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075381400
Date of Patent
May 26, 2009
0Patent Application Number
104928310
Date Filed
February 28, 2003
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07538140 Ester compound and medicinal use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07538140
Date of patent
May 26, 2009
Patent application number
10492831
Date Filed
February 28, 2003
Patent primary examiner
Find more entities like US Patent 7538140 Ester compound and medicinal use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
